Technical Analysis for YGEN - Yourgene Health Plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Very Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
20 DMA Support | Bullish | -1.30% | |
Narrow Range Bar | Range Contraction | -1.30% | |
Inside Day | Range Contraction | -1.30% | |
Wide Bands | Range Expansion | -1.30% | |
20 DMA Support | Bullish | -1.30% | |
Narrow Range Bar | Range Contraction | -1.30% | |
Wide Bands | Range Expansion | -1.30% | |
Narrow Range Bar | Range Contraction | -3.80% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Fell Below Previous Day's Low | 4 days ago |
Down 3% | 4 days ago |
Down 2% | 4 days ago |
Down 1% | 4 days ago |
Fell Below 20 DMA | 4 days ago |
Get this analysis on your stocks daily!
Yourgene Health Plc Description
Yourgene Health PLC, formerly Premaitha Health PLC, is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Medicine Disease Clinic Monitoring Branches Of Biology Earl Diseases Estima Blood In Vitro Laboratories Genetics Medical Genetics Medical Tests Midwifery Molecular Diagnostics
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Date | Title |
---|
Indicator | Value |
---|---|
52 Week High | 10.45 |
52 Week Low | 0.2825 |
Average Volume | 29,569,957 |
200-Day Moving Average | 4.81 |
50-Day Moving Average | 1.05 |
20-Day Moving Average | 0.39 |
10-Day Moving Average | 0.39 |
Average True Range | 0.07 |
RSI | 22.48 |
ADX | 57.05 |
+DI | 14.50 |
-DI | 34.08 |
Chandelier Exit (Long, 3 ATRs) | 0.28 |
Chandelier Exit (Short, 3 ATRs) | 0.48 |
Upper Bollinger Bands | 0.44 |
Lower Bollinger Band | 0.33 |
Percent B (%b) | 0.45 |
BandWidth | 28.52 |
MACD Line | -0.17 |
MACD Signal Line | -0.23 |
MACD Histogram | 0.0616 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.41 | ||||
Resistance 3 (R3) | 0.42 | 0.41 | 0.41 | ||
Resistance 2 (R2) | 0.41 | 0.40 | 0.41 | 0.41 | |
Resistance 1 (R1) | 0.39 | 0.39 | 0.39 | 0.39 | 0.40 |
Pivot Point | 0.39 | 0.39 | 0.38 | 0.38 | 0.39 |
Support 1 (S1) | 0.37 | 0.38 | 0.37 | 0.37 | 0.36 |
Support 2 (S2) | 0.36 | 0.37 | 0.36 | 0.35 | |
Support 3 (S3) | 0.35 | 0.36 | 0.35 | ||
Support 4 (S4) | 0.35 |